These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 5296612)

  • 1. [OCM 505 used in intramuscular and combined administration in the management of labor and hemorrhage in childbirth].
    Río de la Loza F; Saldaña R; Bucio R
    Ginecol Obstet Mex; 1966; 21(121):293-9. PubMed ID: 5296612
    [No Abstract]   [Full Text] [Related]  

  • 2. [The drug management of the placental period induced by traction on the umbilical cord].
    Rehsteiner HP
    Ther Umsch; 1969 Aug; 26(8):450-4. PubMed ID: 5355762
    [No Abstract]   [Full Text] [Related]  

  • 3. [Experience with medicamentous prevention of bleeding during the 3d stage of labor, using oxytocin and methylergometrin].
    Zvarík E; Valentková M
    Cesk Gynekol; 1967 Aug; 32(6):496-8. PubMed ID: 5300589
    [No Abstract]   [Full Text] [Related]  

  • 4. Prevention of postpartum hemorrhage by uterotonic agents: comparison of oxytocin and methylergometrine in the management of the third stage of labor.
    Fujimoto M; Takeuchi K; Sugimoto M; Maruo T
    Acta Obstet Gynecol Scand; 2006; 85(11):1310-4. PubMed ID: 17091409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical trial of intramuscular OCM 505 and intravenous methergin in the third stage of labour.
    Carpén E; Koistinen O; Virkkunen A; Laakso L
    Ann Chir Gynaecol Fenn; 1968; 57(4):473-5. PubMed ID: 4893747
    [No Abstract]   [Full Text] [Related]  

  • 6. [Use of methergin and syntometrin in the conduction of the 3d phase of labor].
    Draca P
    Med Pregl; 1972; 25(3):87-90. PubMed ID: 5034439
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of methylergonovine on puerperal prolactin secretion.
    Weiss G; Klein S; Shenkman L; Kataoka K; Hollander CS
    Obstet Gynecol; 1975 Aug; 46(2):209-10. PubMed ID: 1080266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of deaminooxytocin onblood loss during the 3rd stage of labor].
    Filipowicz K
    Folia Med Cracov; 1974; 16(2):217-34. PubMed ID: 4545404
    [No Abstract]   [Full Text] [Related]  

  • 9. Methylergonovine maleate: a proposal for its more specific use.
    Borri P; Gerli P; Antignani FL; Bindi L; Cozzi C; Moscarella G; Buzzoni P
    Biol Res Pregnancy Perinatol; 1986; 7(3):128-30. PubMed ID: 3490881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Decreased numbers of placental retention after oxytocin compared to methylergometrin].
    Borgvall B; Boström K; Hammar M
    Lakartidningen; 1990 Feb; 87(6):376-7. PubMed ID: 2314178
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug therapy during labor and delivery.
    Kelsey JJ; Prevost RR
    Am J Hosp Pharm; 1994 Oct; 51(19):2394-402; quiz 2504-5. PubMed ID: 7847404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective study of intramuscular ergometrine compared with intramuscular oxytocin for prevention of postpartum hemorrhage.
    Saito K; Haruki A; Ishikawa H; Takahashi T; Nagase H; Koyama M; Endo M; Hirahara F
    J Obstet Gynaecol Res; 2007 Jun; 33(3):254-8. PubMed ID: 17578351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prevention and treatment of uterine hemorrhage in obstetrics with epsilon-aminocaproic acid].
    Shilko NA; Borsuk GT; Gurova IF; Zhurbenko IuK; Matsiuk AG; Franchuk AE; Iushchishina SV
    Vopr Okhr Materin Det; 1968 Sep; 13(9):63-7. PubMed ID: 5304942
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical research with OCM-505; its effects on delivery in 106 parturient].
    Rozas A; Nobre NS; Barros HC; Balsamo S; Sampaio LF; Neme B
    Hospital (Rio J); 1966 Jul; 70(1):191-204. PubMed ID: 5296800
    [No Abstract]   [Full Text] [Related]  

  • 15. A comparison of intramuscular ergometrine maleate and oxytocin with intravenous oxytocin and intramuscular ergometrine in the third stage of labour.
    Beard RJ; Bishop NL; Jones BJ
    Br J Clin Pract; 1973 Jan; 27(1):13-4. PubMed ID: 4539815
    [No Abstract]   [Full Text] [Related]  

  • 16. [Prophylactic use of methylergometrine and oxytocin in the placental and early puerperal stages].
    Zeinalova AG
    Akush Ginekol (Mosk); 1970 May; 46(5):71-4. PubMed ID: 5312468
    [No Abstract]   [Full Text] [Related]  

  • 17. [Biphasic active management of the 3d stage of labor in the aspect of hemorrhage prevention in the placental period and elimination of placental retainment due to impaction].
    Durek M; Pietkiewicz D; Suchocki S
    Pol Tyg Lek; 1973 Jun; 28(23):867-8. PubMed ID: 4541697
    [No Abstract]   [Full Text] [Related]  

  • 18. [Use of epsilon-caproic acid in the treatment of obstetric hypofibrinogenemia].
    Loria Mendez M; Karchmer S; Dominguez JL; Martinez L
    Ginecol Obstet Mex; 1966; 21(125):997-1016. PubMed ID: 5301768
    [No Abstract]   [Full Text] [Related]  

  • 19. CLINICAL EXPERIENCE WITH SIMULTANEOUS INTRAMUSCULAR INJECTION OF OXYTOCIN AND METHYLERMETRINE.
    SOIVA K; KOISTINEN O
    Ann Chir Gynaecol Fenn; 1964; 53():173-8. PubMed ID: 14163868
    [No Abstract]   [Full Text] [Related]  

  • 20. [Methergin].
    Gervais C
    Soins; 1982 Mar; (10):33. PubMed ID: 6979092
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.